Merck discard jumps straight to the top of the chart of the most expensive drugs in the US at $1M-plus
Back late last fall, when Eiger Pharmaceuticals $EIGR completed its victory lap with an old Merck discard it had developed for rare cases of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
